Federico Cucchiara - Concepedia

Author

Federico Cucchiara

University of Pisa ORCID

Also Known As

F. Cucchiara, Federico Cucchiara, Italian Multicentric Group on clock genes, actigraphy in AD

Publications

860

Citations

H-Index

Concepts

All Affiliations

University of Pisa Azienda Ospedaliera Universitaria Pisana University of Pavia Fondazione Stella Maris University of Campania "Luigi Vanvitelli"

About

Federico Cucchiara is an author at University of Pisa specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	96
2	Pharmacology	3	3	48
3	Pathology	2	2	51
4	Biochemistry	1	1	16
5	Cell Biology	1	1	36

Federico Cucchiara

Publications

343

Citations

H-Index

Page 1

	Year	Citations
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide Marzia Del Re, Vincenza Conteduca, Stefania Crucitta, Prostate Cancer and Prostatic Diseases	2021	55
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer Federico Cucchiara, Marzia Del Re, Simona Valleggi, Frontiers in Oncology	2020	39
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer’s Disease Reveals Sex Differences Biancamaria Guarnieri, Michelangelo Maestri, Federico Cucchiara, Journal of Alzheimer s Disease	2020	38
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC Marzia Del Re, Federico Cucchiara, Eleonora Rofi, Cancer Immunology Immunotherapy	2020	37
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients Marzia Del Re, Stefania Crucitta, Giulia Lorenzini, Pharmacological Research Breast OncologyMedicinePathologyBreast CancerCdk4/6 Inhibitors	2020	36
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer Stefania Crucitta, Martina Ruglioni, Claudia Novi, Clinica Chimica Acta	2023	33
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs Marzia Del Re, Stefania Crucitta, Federico Paolieri, Journal of Translational Medicine	2022	21
Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics Teresa Di Desidero, Paola Orlandi, Anna Fioravanti, Biochemical Pharmacology OncologyChemoprevention StrategyMedicineMetronomic TherapyPharmacotherapy	2019	17
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference mass spectrometry Giacomo Luci, Federico Cucchiara, Laura Ciofi, Journal of Pharmaceutical and Biomedical Analysis BiochemistryMedicineDrug DiscoveryBioanalysisMass Spectrometry	2020	16
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel Caterina Vivaldi, Stefania Crucitta, Silvia Catanese, The Pharmacogenomics Journal Comprehensive Pharmacogenetic AnalysisOncologyPancreatic CancerMedicineAbcb1 Polymorphisms	2021	15

Page 1